Old Mutual Plc – Form 8.3 – Public Opening Position Disclosure Clinigen Group Plc

OML 201709130031A
Form 8.3 – Public Opening Position Disclosure – Clinigen Group Plc

OLD MUTUAL PLC
ISIN CODE: GB00B77J0862
JSE SHARE CODE: OML
NSX SHARE CODE: OLM
ISSUER CODE: OLOMOL
Old Mutual
FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Old Mutual plc
(and subsidiaries)
(b) Owner or controller of interests and short
positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient. For a trust, the trustee(s), settlor and
beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose Clinigen Group Plc
relevant securities this form relates:
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity
of offeror/offeree:
(e) Date position held/dealing undertaken: 12/09/2017
For an opening position disclosure, state the latest
practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the Quantum Pharma Plc
discloser making disclosures in respect of any
other party to the offer?
If it is a cash offer or possible cash offer, state
“N/A”

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant
securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.1p Ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned 7,446,296 6.46%
and/or controlled:
(2) Cash-settled derivatives:

(3) Stock-settled derivatives
(including options) and

agreements to
purchase/sell:
7,446,296 6.46%
TOTAL:
Please note we do not have voting rights within 219,780 of the above total holdings.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements
to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee
options)

Class of relevant security in relation to
which subscription right exists:
Details, including nature of the rights
concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class
of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
Ordinary Purchase 16,556 11.12 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description e.g. opening/closing a reference unit
security e.g. CFD long/short position, securities
increasing/reducing a
long/short position

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class Product Writing, Number Exercis Type Expir Option
of descriptio purchasin of e price e.g. y money
relevan n e.g. call g, selling, securitie per unit America date paid/
t option varying s to n, receive
securit etc. which Europea d per
y option n etc. unit
relates

(ii) Exercise

Class of Product Exercising/ Number of Exercise price
relevant description exercised securities per unit
security e.g. call option against

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if
security e.g. subscription, applicable)
conversion

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to
deal or refrain from dealing entered into by the person making the disclosure and
any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to
which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? No

Date of disclosure:
0B 13 September 2017

Contact name:
1B Rose Coyle

Telephone number:
2B 0207 002 7503

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service
and must also be emailed to the Takeover Panel at [email protected] The Panel’s
Market Surveillance Unit is available for consultation in relation to the Code’s disclosure
requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Sponsor:
Merrill Lynch South Africa (Pty) Ltd

Joint Sponsor:
Nedbank Corporate and Investment Banking

Date: 13/09/2017 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (‘JSE’).
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.